2025 年 3D 生物列印全球市場報告

預計未來幾年 3D 生物列印市場規模將呈指數級成長。到 2029 年，這一數字將成長至 51.1 億美元，複合年成長率為 23.3%。預測期內的成長可歸因於醫學進步、生物列印皮膚的發展、患者意識的提高以及人口老化。預測期內的關鍵趨勢包括多材料列印、血管生成技術、器官晶片、客自訂植入和太空生物製造。

預計在預測期內，政府和私人對 3D 生物列印研究活動的支持資金將不斷增加，從而推動 3D 生物列印市場的成長。 3D生物列印在醫學領域的應用越來越廣泛，並吸引了政府和私人組織的資助。該資金為3D生物列印技術的各個發展階段提供資金和技術支援。例如，2022年5月，瑞士生物列印公司Readily3d SA獲得歐盟60萬美元資助，利用該公司的Tomolite 3D生物列印技術開發胰臟活體微型模型。澳洲衛生部長向科廷大學撥款 737,690 美元，用於開發和最佳化 3D 技術，將皮膚組織直接生物列印到模型傷口中，作為人體皮膚修復的先決條件。

預計慢性病的增加將成為未來 3D 生物列印市場成長的一個促進因素。由於慢性病通常持續超過三個月且常常伴隨終生，3D 生物列印擴大被用於創建組織模型，以輔助慢性病研究和潛在的器官替代療法。例如，根據世界衛生組織（WHO）2022年9月發布的報告，全球整體每年約有4,100萬人死亡，佔全部死亡人數的74%。這驚人的數字包括1,790萬人死於心血管疾病，930萬人死於癌症，410萬人死於慢性呼吸道疾病，200萬人死於糖尿病。因此，慢性病的快速成長是3D生物列印市場成長的主要驅動力。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球 3D 生物列印 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素、限制因素）
• 最終用途產業分析
• 全球3D生物列印市場成長率分析
• 全球 3D 生物列印市場表現：規模與成長，2019 年至 2024 年
• 全球 3D 生物列印市場預測：規模與成長，2024-2029 年，2034 年
• 全球 3D 生物列印總目標市場 (TAM)

第6章 市場細分

• 全球 3D 生物列印市場（按組件、性能和預測）2019-2024、2024-2029、2034
• 3D生物列印機
• 生物墨水
• 全球 3D 生物列印市場（按材料、性能和預測），2019-2024 年、2024-2029 年、2034 年
• 活細胞
• 水凝膠
• 細胞外基質
• 其他
• 全球 3D 生物列印市場（按應用、性能和預測），2019-2024 年、2024-2029 年、2034 年
• 研究用途
• 臨床應用
• 其他
• 全球 3D 生物列印市場（按最終用戶、性能和預測）2019-2024、2024-2029、2034
• 研究和學術機構
• 生物製藥公司
• 醫院
• 其他
• 全球 3D 生物列印市場類型、效能及預測，2019-2024、2024-2029、2034
• 噴墨3D生物列印機
• 微擠出3D生物列印機
• 雷射輔助3D生物列印機
• 立體光刻技術(SLA) 生物印表機
• 全球 3D 生物列印市場（按生物墨水、性能和預測），2019-2024 年、2024-2029 年、2034 年
• 天然生物墨水
• 合成生物墨水
• 混合生物墨水
• 水凝膠

第7章 區域和國家分析

• 全球 3D 生物列印市場各地區、績效及預測，2019-2024、2024-2029、2034
• 全球 3D 生物列印市場（依國家/地區分類）、績效及預測，2019-2024、2024-2029、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第 17 章 德國市場

第 18 章 法國市場

第 19 章：義大利市場

第 20 章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第 25 章：加拿大市場

第26章 南美洲市場

第 27 章：巴西市場

第28章 中東市場

第 29 章：非洲市場

第 30 章競爭格局與公司概況

• 3D 生物列印市場：競爭格局
• 3D 生物列印市場：公司簡介
  • Organovo Holdings Inc.
  • Allevi Inc.
  • Cellink AB
  • Aspect Biosystems Ltd.
  • 3D Systems Corporation

第31章 其他大型創新企業

• Cyfuse Biomedical KK
• EnvisionTEC GmbH
• Poietis SA
• TeVido BioDevices
• Nano3D Biosciences Inc.
• Digilab Inc.
• RegenHU Ltd.
• GeSiM mbH
• Advanced Solutions Life Sciences LLC
• Regenovo BIoTechnology Co. Ltd.
• Regemat 3D SL
• Bio3D Technologies
• Stratasys Ltd.
• ROKIT Healthcare Co. Ltd.
• Inventia Life Science Pvt. Ltd.

第 32 章 全球競爭基準化分析與儀錶板

第33章 重大併購

第 34 章 近期市場趨勢

第 35 章：市場潛力大的國家與策略

• 2029 年 3D 生物列印市場 - 提供最多新機會的國家
• 2029 年 3D 生物列印市場 - 提供最新興機會的細分市場
• 3D 生物列印市場 2029-成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第 36 章 附錄

3D Bioprinting, a form of additive manufacturing, involves the layer-by-layer printing of live structures that emulate the behavior of living systems. This process utilizes cells and biocompatible materials, commonly referred to as bio-inks. The primary application of 3D bioprinting materials is in drug research, and more recently, in the creation of cell scaffolds for repairing damaged ligaments and joints.

The key components in 3D bioprinting include 3D bioprinters and bio-inks. 3D bioprinters employ three-dimensional technology along with biocompatible materials to replicate various body parts, facilitating the bioprinting of tissues, bones, organs, blood vessels, and biomedical components. The materials involved in the process encompass living cells, hydrogels, extracellular matrices, and others. The application of 3D bioprinting extends to research and clinical settings, among others, and finds implementation in diverse sectors such as research organizations, academic institutes, biopharmaceutical companies, hospitals, and more.

The 3D bioprinting market research report is one of a series of new reports from The Business Research Company that provides 3D bioprinting market statistics, including 3D bioprinting industry global market size, regional shares, competitors with a 3D bioprinting market share, detailed 3D bioprinting market segments, market trends and opportunities, and any further data you may need to thrive in the 3D bioprinting industry. This 3D bioprinting market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The 3D bioprinting market size has grown rapidly in recent years. It will grow from $1.86 billion in 2024 to $2.21 billion in 2025 at a compound annual growth rate (CAGR) of 19.1%. The growth in the historic period can be attributed to research and development funding, growth in chronic diseases, organ shortage, rise in pharmaceutical testing, growth in tissue engineering.

The 3D bioprinting market size is expected to see exponential growth in the next few years. It will grow to $5.11 billion in 2029 at a compound annual growth rate (CAGR) of 23.3%. The growth in the forecast period can be attributed to healthcare advancements, rising development of bioprinted skin, growing awareness among patients, aging population. Major trends in the forecast period include multi-material printing, vascularization techniques, organ-on-a-chip, custom implants, biofabrication in space.

Rising governments and private funding to support 3D bioprinting research activities are expected to drive the growth of the 3D bioprinting market in the forecast period. 3D bioprinting is increasing applications in healthcare attracted funding from government and private organizations. This funding provides financial and technical assistance across different development phases of 3D bioprinting techniques. For instance, in May 2022, Readily3d SA, a Switzerland-based bioprinting company, received funding of $600,000 from the European Union to develop a living miniature model of the pancreas using its Tomolite 3D bioprinting technique. The Australian Minister for Health funded Curtin University with $737,690 to develop and optimize 3D technology for bioprinting skin tissue directly onto model wounds as a prelude to human skin restoration

The anticipated rise in chronic diseases is set to be a driving factor in the prospective growth of the 3D bioprinting market. Chronic diseases, persisting over extended periods-typically three months or more, and often for a person's lifetime-have increasingly utilized 3D bioprinting for creating tissue models, aiding in chronic disease research and potential organ replacement therapies. For example, as per the World Health Organization's September 2022 report, approximately 41 million deaths globally annually, representing 74% of fatalities, are attributed to non-communicable diseases (NCDs) or chronic diseases. This alarming figure includes 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Consequently, the upsurge in chronic diseases is a significant driver behind the growth of the 3D bioprinting market.

Leading companies in the 3D bioprinting market are focusing on developing next-generation bioprinters for use in tissue engineering and regenerative medicine. A bio 3D printer is a specialized device that constructs biological structures, such as tissues and organs, using bioinks made from living cells or biocompatible materials. For example, in November 2022, Avay Biosciences, an India-based healthcare company, launched the Mito Plus. This printer facilitates the creation of complex human tissues, addressing critical challenges like organ shortages and improving drug testing methodologies. Key features include precise temperature control (ranging from 4°C to 80°C), a dual-extruder system for multiple biomaterials, inbuilt UV curing to enhance tissue quality, and HEPA filters to maintain a sterile printing environment

Major companies in the 3D bioprinting market are focusing on developing innovative technological solutions, such as 3D bioprinters, to improve precision and efficiency in tissue engineering and regenerative medicine. 3D bioprinters are devices that utilize bioinks containing living cells to produce three-dimensional tissue and organ structures for medical research and regenerative medicine applications. For example, in June 2024, Tethon 3D, a US-based developer of ceramic powder and metal-polymer products, introduced the Bison Bio DLP 3D bioprinter, marking its entry into the bioprinting market. Developed in collaboration with Carima, this advanced printer offers adjustable build sizes (30 X 20 mm, 57 X 32 mm, and 96 X 54 mm) and is compatible with Tethon's proprietary LAP photoinitiator and GelMA hydrogel bioink, crucial for bioprinting living tissues. Measuring 24 X 24 X 24 inches and weighing 75 lbs, the Bison Bio is priced at $19,950 and aims to drive advancements in healthcare by enabling the creation of complex tissues and organs for biomedical research, supporting personalized medicine and regenerative therapies

In May 2022, BICO, a biotechnology company from Sweden focused on 3D bioprinting technology, announced the acquisition of Allegro 3D, Inc. for $6 million. This acquisition is intended to support BICO's strategic objectives by incorporating advanced technology and broadening its market reach. Allegro 3D, Inc., located in San Diego, specializes in light-based printing technology, which enhances BICO's current capabilities.

Major companies operating in the 3D bioprinting market include Organovo Holdings Inc., Allevi Inc., Cellink AB, Aspect Biosystems Ltd., 3D Systems Corporation, Cyfuse Biomedical KK, EnvisionTEC GmbH, Poietis SA, TeVido BioDevices, Nano3D Biosciences Inc., Digilab Inc., RegenHU Ltd., GeSiM mbH, Advanced Solutions Life Sciences LLC, Regenovo Biotechnology Co. Ltd., Regemat 3D S.L., Bio3D Technologies, Stratasys Ltd., ROKIT Healthcare Co. Ltd., Inventia Life Science Pvt. Ltd., Vivax Bio LLC, GE HealthCare Technologies Inc., 3D Biotek LLC, Nuclera Nucleics Ltd., 3D Fortify Inc., Carbon Inc., Divergent Technologies Inc., Markforged Inc., SprintRay Inc., 3D Bio Corp, 3D Bioprinting Solutions, BICO Group AB, CollPlant Biotechnologies Ltd., Shining 3D Tech Co. Ltd., 3Dynamic Systems Ltd., Modern Meadow Inc.

North America was the largest region in the 3D bioprinting market in 2024. The Asia-Pacific is expected to be the fastest-growing region in the 3D bioprinting market during the forecast period. The regions covered in the 3D bioprinting market report analysis are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the 3D bioprinting market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The 3D bioprinting market consists of sales of extrusion-based bioprinting, inkjet-based bioprinting, laser-assisted bioprinting, and stereolithography bioprinting. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

3D Bioprinting Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on 3d bioprinting market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for 3d bioprinting ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The 3d bioprinting market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: 3D Bioprinters; Bioinks
• 2) By Material: Living Cells; Hydrogels; Extracellular Matrices; Other Materials
• 3) By Application: Research Applications; Clinical Application; Other Applications
• 4) By End User: Research Organization And Academic Institutes; Biopharmaceuticals Companies; Hospitals; Other End Users
• Subsegments:
• 1) By 3D Bioprinters: Inkjet 3D Bioprinters; Microextrusion 3D Bioprinters; Laser-Assisted 3D Bioprinters; Stereolithography (SLA) Bioprinters
• 2) By Bioinks: Natural Bioinks; Synthetic Bioinks; Hybrid Bioinks; Hydrogels
• Companies Mentioned: Organovo Holdings Inc.; Allevi Inc.; Cellink AB; Aspect Biosystems Ltd.; 3D Systems Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. 3D Bioprinting Market Characteristics

3. 3D Bioprinting Market Trends And Strategies

4. 3D Bioprinting Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global 3D Bioprinting Growth Analysis And Strategic Analysis Framework

• 5.1. Global 3D Bioprinting PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global 3D Bioprinting Market Growth Rate Analysis
• 5.4. Global 3D Bioprinting Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global 3D Bioprinting Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global 3D Bioprinting Total Addressable Market (TAM)

6. 3D Bioprinting Market Segmentation

• 6.1. Global 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 3D Bioprinters
• Bioinks
• 6.2. Global 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Living Cells
• Hydrogels
• Extracellular Matrices
• Other Materials
• 6.3. Global 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Research Applications
• Clinical Application
• Other Applications
• 6.4. Global 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Research Organization And Academic Institutes
• Biopharmaceuticals Companies
• Hospitals
• Other End Users
• 6.5. Global 3D Bioprinting Market, Sub-Segmentation Of 3D Bioprinters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inkjet 3D Bioprinters
• Microextrusion 3D Bioprinters
• Laser-Assisted 3D Bioprinters
• Stereolithography (SLA) Bioprinters
• 6.6. Global 3D Bioprinting Market, Sub-Segmentation Of Bioinks, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural Bioinks
• Synthetic Bioinks
• Hybrid Bioinks
• Hydrogels

7. 3D Bioprinting Market Regional And Country Analysis

• 7.1. Global 3D Bioprinting Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global 3D Bioprinting Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific 3D Bioprinting Market

• 8.1. Asia-Pacific 3D Bioprinting Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China 3D Bioprinting Market

• 9.1. China 3D Bioprinting Market Overview
• 9.2. China 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India 3D Bioprinting Market

• 10.1. India 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan 3D Bioprinting Market

• 11.1. Japan 3D Bioprinting Market Overview
• 11.2. Japan 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia 3D Bioprinting Market

• 12.1. Australia 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia 3D Bioprinting Market

• 13.1. Indonesia 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea 3D Bioprinting Market

• 14.1. South Korea 3D Bioprinting Market Overview
• 14.2. South Korea 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe 3D Bioprinting Market

• 15.1. Western Europe 3D Bioprinting Market Overview
• 15.2. Western Europe 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK 3D Bioprinting Market

• 16.1. UK 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany 3D Bioprinting Market

• 17.1. Germany 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France 3D Bioprinting Market

• 18.1. France 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy 3D Bioprinting Market

• 19.1. Italy 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain 3D Bioprinting Market

• 20.1. Spain 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe 3D Bioprinting Market

• 21.1. Eastern Europe 3D Bioprinting Market Overview
• 21.2. Eastern Europe 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia 3D Bioprinting Market

• 22.1. Russia 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America 3D Bioprinting Market

• 23.1. North America 3D Bioprinting Market Overview
• 23.2. North America 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA 3D Bioprinting Market

• 24.1. USA 3D Bioprinting Market Overview
• 24.2. USA 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada 3D Bioprinting Market

• 25.1. Canada 3D Bioprinting Market Overview
• 25.2. Canada 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America 3D Bioprinting Market

• 26.1. South America 3D Bioprinting Market Overview
• 26.2. South America 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil 3D Bioprinting Market

• 27.1. Brazil 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East 3D Bioprinting Market

• 28.1. Middle East 3D Bioprinting Market Overview
• 28.2. Middle East 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa 3D Bioprinting Market

• 29.1. Africa 3D Bioprinting Market Overview
• 29.2. Africa 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. 3D Bioprinting Market Competitive Landscape And Company Profiles

• 30.1. 3D Bioprinting Market Competitive Landscape
• 30.2. 3D Bioprinting Market Company Profiles
  • 30.2.1. Organovo Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Allevi Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Cellink AB Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Aspect Biosystems Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. 3D Systems Corporation Overview, Products and Services, Strategy and Financial Analysis

31. 3D Bioprinting Market Other Major And Innovative Companies

• 31.1. Cyfuse Biomedical KK
• 31.2. EnvisionTEC GmbH
• 31.3. Poietis SA
• 31.4. TeVido BioDevices
• 31.5. Nano3D Biosciences Inc.
• 31.6. Digilab Inc.
• 31.7. RegenHU Ltd.
• 31.8. GeSiM mbH
• 31.9. Advanced Solutions Life Sciences LLC
• 31.10. Regenovo Biotechnology Co. Ltd.
• 31.11. Regemat 3D S.L.
• 31.12. Bio3D Technologies
• 31.13. Stratasys Ltd.
• 31.14. ROKIT Healthcare Co. Ltd.
• 31.15. Inventia Life Science Pvt. Ltd.

32. Global 3D Bioprinting Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The 3D Bioprinting Market

34. Recent Developments In The 3D Bioprinting Market

35. 3D Bioprinting Market High Potential Countries, Segments and Strategies

• 35.1 3D Bioprinting Market In 2029 - Countries Offering Most New Opportunities
• 35.2 3D Bioprinting Market In 2029 - Segments Offering Most New Opportunities
• 35.3 3D Bioprinting Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer